scholarly journals Editorial

2021 ◽  
Vol 11 (1-2) ◽  
pp. v-xx

At the dawn of the devastating events of the COVID-19 pandemic, in the editorial of the first issue of 2020, as well as in the articles, topics related to the overwhelming impact of the emerging crisis were explored (Van der Maesen 2020). In particular, reference was made to the topical performances of the federal governments of the United States and Brazil, as well as the British government. As an introduction to this special issue, it is interesting to recall and extend some of the observations that were made last year.In the case of the United States, when COVID-19 appeared, the hazards of the virus were downplayed and even neglected. The president countered the opinion of public health experts with false, misleading comparisons to other countries (Qiu 2020). It was proposed to cut the budget of the US Centres for Disease Control and Prevention by 16 percent starting in October 2020. Long-lasting contacts and collaboration with the World Health Organization were broken. Due to export restrictions on medical products, importing countries were unable to obtain sufficient medical equipment, resulting in a shortage in healthcare equipment that had to be made for up via a mandatory increase in local production. This came at a high cost and with serious delays (Krueger 2020). For the United States itself, the initial attitude of the government resulted in a dramatic blow to its public health resources and capabilities. The quality of hundreds of health departments around the country suggests that the nation may be less prepared for the next pandemic than it was for the current one (Baker and Ivory 2021). The violence toward public health professions is gradually taking shape (Schreiber 2021). An overriding societal pattern, which in the United States undermines the principles of effective public health, is the primacy of personal rights over collective responsibility and solidarity. More than half of US states have introduced new laws to restrict public health measures, including policies requiring quarantine and mandating vaccines and/or masks.

2009 ◽  
Vol 7 (4) ◽  
pp. 9
Author(s):  
Atresha Karra, JD ◽  
Emily Cornette, JD

This article focuses on the existing methods for tracking and restricting the spread of communicable diseases, both within United States borders and across nations. It will first describe the roles played by the United States’ Centers for Disease Control and Prevention and the World Health Organization and will then explore how communicable diseases across the world are identified and monitored. This will be followed by a discussion of US and world reporting requirements and methods. Finally, the article will discuss the tactics used by the United States to control the spread of disease.


2020 ◽  
Vol 67 (1) ◽  
pp. 6-6
Author(s):  
Ken Thai

Pharmacists and our fellow healthcare colleagues typically expect a break from our “high season” of cough, cold, and flu patients that have filled our pharmacies, clinics, and hospitals by this time of the year. Everyone is prepping for the end of the winter and the dawning of spring. This year was unlike many as we have heard loud cries across the globe regarding the outbreak of the novel “new” coronavirus. The virus was first detected from the Wuhan City of China. It has since infected tens of thousands of people in China and across the world. In fact, the World Health Organization has declared the outbreak a “public health emergency of international concern.” Health and Human Services Secretary Alex Azar declared a public health emergency for the United States to aid the nation's healthcare community in responding. A proclamation was signed on January 31, 2020, by the United States to suspend entry of anyone who poses a risk of transmitting the coronavirus.


2011 ◽  
Vol 2 (2) ◽  
pp. 11-13 ◽  

In 2006, the Centers for Disease Control and Prevention (CDC), the National Institutes of Health, and the American Academy of Pediatrics convened an expert panel to review scientific evidence and discuss the potential use of the new WHO growth charts in clinical settings in the United States. On the basis of input from this expert panel, CDC recommends that clinicians in the United States use the 2006 WHO international growth charts, rather than the CDC growth charts, for children aged <24 months (available at https://www.cdc.gov/growthcharts). The CDC growth charts should continue to be used for the assessment of growth in persons aged 2–19 years.


2013 ◽  
Vol 29 (7) ◽  
pp. 1277-1290
Author(s):  
José Cassio de Moraes ◽  
Telma Carvalhanas ◽  
Lucia Ferro Bricks

The aim of this study was to describe recent changes in the epidemiology of pertussis and existing policies regarding recommended and mandatory occupational vaccinations for healthcare professionals (HCPs). The authors carried out an extensive review of references on the PubMed and SciELO databases and the official sites of the World Health Organization, Pan American Health Organization, Centers for Disease Control and Prevention, and Brazilian Ministry of Health, using the keywords pertussis, vaccines and healthcare professionals. Vaccination against pertussis is recommended for HCPs in the United States, Canada, nine European countries, Australia, Hong Kong, Singapore, Costa Rica, Argentina and Uruguay, and in some countries it is compulsory. In Brazil, only one publication discussing the risk of pertussis among HCPs was found. Considering the reemergence of pertussis and the great number of associated hospitalizations and deaths registered in 2011, it is necessary to review public policies regarding HCP pertussis vaccination, particularly among workers in frequent contact with young babies.


2021 ◽  
Vol 46 (4) ◽  
pp. 1-2
Author(s):  
Joseph Meaney ◽  

COVID-19 vaccine passports run the risk of creating a divided society where social privileges or restrictions based on “fitness” lead to discrimination based on immunization status. Individuals have a strong right to be free of coercion to take a COVID-19 vaccine, and we should be very leery of further invasion of private medical decisions. These concerns are shared both internationally and in the United States, and the World Health Organization, the Biden administration, and many US governors oppose COVID-19 vaccine credentials. In addition, regulations for COVID-19 vaccine credentials face practical barriers, including lack of access globally, especially among the poor; and lack of scientific data on the efficacy of these vaccines.


2021 ◽  
Author(s):  
Sarah Kreps

BACKGROUND Misinformation about COVID-19 has presented challenges to public health authorities during pandemics. Understanding the prevalence and type of misinformation across contexts offers a way to understand the discourse around COVID-19 while informing potential countermeasures. OBJECTIVE The aim of the study was to study COVID-19 content on two prominent microblogging platform, Twitter, based in the United States, and Sina Weibo, based in China, and compare the content and relative prevalence of misinformation to better understand public discourse of public health issues across social media and cultural contexts. METHODS A total of 3,579,575 posts were scraped from both Weibo and Twitter, focusing on content from January 30th, 2020, when the World Health Organization (WHO) declared COVID-19 a “Public Health Emergency of International Concern” and February 6th, 2020. A 1% random sample of tweets that contained both the English keywords “coronavirus” and “covid-19” and the equivalent Chinese characters was extracted and analyzed based on changes in the frequencies of keywords and hashtags. Misinformation on each platform was compared by manually coding and comparing posts using the World Health Organization fact-check page to adjudicate accuracy of content. RESULTS Both platforms posted about the outbreak and transmission but posts on Sina Weibo were less likely to reference controversial topics such as the World Health Organization and death and more likely to cite themes of resisting, fighting, and cheering against the coronavirus. Misinformation constituted 1.1% of Twitter content and 0.3% of Weibo content. CONCLUSIONS Quantitative and qualitative analysis of content on both platforms points to cross-platform differences in public discourse surrounding the pandemic and informs potential countermeasures for online misinformation.


PEDIATRICS ◽  
1977 ◽  
Vol 60 (6) ◽  
pp. 797-804
Author(s):  
Myron E. Wegman

Data for this article, as in previous reports,1 are drawn principally from the Monthly Vital Statistics Report,2-5 published by the National Center for Health Statistics. The international data come from the Demographic Yearbook6 and the quarterly Population and Vital Statistics Report,7 both published by the Statistical Office of the United Nations, and the World Health Statistics Report,8 published by the World Health Organization. All the United States data for 1976 are estimates by place of occurrence based upon a 10% sample of material received in state offices between two dates, one month apart, regardless of when the event occurred. Experience has shown that for the country as a whole the estimate is very close to the subsequent final figures.


2018 ◽  
Author(s):  
John W. Martel ◽  
Scott McCorvey

Diarrhea is a common emergency department (ED) complaint, leading to more than 1.5 million outpatient visits and 200,000 hospital admissions in the United States alone. Although concomitant dehydration also exists in some cases, there are no standard clinical criteria to aid in identifying those children who merit intravenous resuscitation. Current pediatric volume repletion guidelines are based primarily on the estimated degree of volume depletion per the World Health Organization, Centers for Disease Control and Prevention, and American Academy of Pediatrics criteria. These practice guidelines stratify patients into mild (3 to 5% volume depletion), moderate (5 to 10% volume depletion), and severe (> 10% volume depletion).  This review contains 5 figures, 9 tables, and 64 references. Key Words: Clostridium difficile, dehydration, diarrhea, gastroenteritis, hemolytic-uremic syndrome, pediatrics


Diagnostics ◽  
2019 ◽  
Vol 9 (3) ◽  
pp. 91 ◽  
Author(s):  
Mateo Cortes Rivera ◽  
Claudio Mastronardi ◽  
Claudia Silva-Aldana ◽  
Mauricio Arcos-Burgos ◽  
Brett Lidbury

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic disease of unknown aetiology that is recognized by the World Health Organization (WHO) and the United States Center for Disease Control and Prevention (US CDC) as a disorder of the brain. The disease predominantly affects adults, with a peak age of onset of between 20 and 45 years with a female to male ratio of 3:1. Although the clinical features of the disease have been well established within diagnostic criteria, the diagnosis of ME/CFS is still of exclusion, meaning that other medical conditions must be ruled out. The pathophysiological mechanisms are unclear but the neuro-immuno-endocrinological pattern of CFS patients gleaned from various studies indicates that these three pillars may be the key point to understand the complexity of the disease. At the moment, there are no specific pharmacological therapies to treat the disease, but several studies’ aims and therapeutic approaches have been described in order to benefit patients’ prognosis, symptomatology relief, and the recovery of pre-existing function. This review presents a pathophysiological approach to understanding the essential concepts of ME/CFS, with an emphasis on the population, clinical, and genetic concepts associated with ME/CFS.


Sign in / Sign up

Export Citation Format

Share Document